Psychiatric medications such as antipsychotics and antidepressants account for a huge number of published research studies. This existing research, however, is almost exclusively constrained within a medical model approach, purporting to evaluate medications as treatment for biological brain disorders, and designing studies accordingly. The disease, and how medications presumably affect it, is at the center — with pharmaceutical company financial interests not far behind. That paradigm is starting to change.
A study published in the journal Pediatrics reveals large differences from one pediatrician to the next when it comes to diagnosing and prescribing drugs for ‘ADHD.’ The researchers found that the percentage of children being diagnosed with ‘ADHD’ varied from as high as 16% of patients at some offices to as little as 1% of patients at others. The data also revealed significant but lower variability in the pediatric diagnosis of anxiety and depression.
Mental health campaigner Chrys Muirhead’s blog features video from the All-Party Parliamentary Group for Prescribed Drug Dependence event on 11 May 2016 at Westminster. “Robert Whitaker, the Pulitzer-shortlisted science journalist and author, presented global prescribing and disability data, as well as research which shows how long-term use of psychiatric drugs, including antidepressants, can lead to worse outcomes for patients.”
For Aeon, Samira Thomas writes that while resilience is attracting a lot of attention from psychology, patience in an underexplored and undervalued virtue in the face of suffering. “Unlike resilience, which implies returning to an original shape, patience suggests change and allows the possibility of transformation as a means of overcoming difficulties,” she writes. “It is a simultaneous act of defiance and tenderness, a complex existence that gently breaks barriers.”
“In Nunatsiavut, climate change is already a terrible reality, and it’s taking a heavy toll on mental health,” Ellie Robins reports for the influence. “In Nunatsiavut, land is once again being taken from communities that have lived on it for thousands of years. This time, it’s not being snatched by colonialists. Instead, it’s changing, disappearing, possibly becoming uninhabitable as a result of the behaviors of other, richer people, elsewhere.”
The latest from Martha Rosenberg: “Pharma companies love disease awareness advertising because, unlike direct-to-consumer (DTC) advertising, risks and warnings of possible drug treatments do not have to be listed.”
Much has been written lately about an “epidemic” of opioid overdose deaths, in some cases advocating for a blanket reduction in the availability of prescription opioids. Regrettably, many readers will not penetrate beneath the sensational headlines to grapple with the complicated realities of this issue. Few who aren’t themselves in pain may realize what harm such articles are doing to tens of millions of people.
Researchers at Duke University who studied 183 adolescents for three years found that increased depression associated with poverty may be mediated by epigenetic changes in DNA. The researchers conclude: "These initial results suggest a speciﬁc biological mechanism through which adversity contributes to altered brain function, which in turn moderates the emergence of general liability as individual risk for mental illness. If replicated, this prospective pathway may represent a novel target biomarker for intervention and prevention among high-risk individuals."
While an estimated 74-percent of patients diagnosed with major depression receive a prescription for an antidepressant, new research reveals that mindfulness-based cognitive therapy (MBCT) may be most helpful when drugs are not used. The study, published in the current issue of Psychotherapy and Psychosomatics, found that the participants in a randomized control trial for MBCT who showed the greatest improvement were those who had not taken antidepressants.
PsychAlive is releasing a new blog and e-course on “Making Sense of Your Life,” with psychologists Lisa Firestone and Dan Siegel. They draw upon the latest neurobiological research, attachment theory and clinical experience to guide participants through the process of creating a coherent narrative around past traumas.
Copyright © 2016 Mad in America Foundation.